ELAN (Elanco Animal Health Incorporated) Stock Financials & Earnings

ELANElanco Animal Health Incorporated

Mkt Cap$12B

Revenue (TTM)$4.7B

Net Income (TTM)-$232M

EPS (TTM)-$0.47

Free Cash Flow (TTM)$284M

Gross Margin46.4%

Op. Margin5.3%

Net Margin-4.9%

FCF Margin6.0%

P/S Ratio (TTM)2.5x

P/E Ratio (TTM)—

YoY Rev Growth+6.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$1.3B	$629M	$221M
Q2 23	$1.1B	$487M	$53M
Q3 23	$1.1B	$441M	$42M
Q4 23	$1.0B	$381M	$10M
Q1 24	$1.2B	$557M	$133M
Q2 24	$1.2B	$558M	$115M
Q3 24	$1.0B	$405M	-$5M
Q4 24	$1.0B	$389M	$8M
Q1 25	$1.2B	$556M	$121M
Q2 25	$1.2B	$577M	$85M
Q3 25	$1.1B	$607M	$27M
Q4 25	$1.1B	$450M	$19M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$81M	—	$327M
Q2 23	$81M	—	$353M
Q3 23	$86M	—	$313M
Q4 23	$79M	—	$292M
Q1 24	$87M	—	$337M
Q2 24	$89M	—	$354M
Q3 24	$87M	—	$323M
Q4 24	$81M	—	$300M
Q1 25	$94M	—	$341M
Q2 25	$92M	—	$400M
Q3 25	$89M	$351M	—
Q4 25	$93M	—	$338M

Revenue Segments

Quarter

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$318M	$0	$318M
Q2 23	$367M	$0	$367M
Q3 23	$369M	$0	$369M
Q4 23	$352M	$0	$352M
Q1 24	$345M	$0	$345M
Q2 24	$416M	$0	$416M
Q3 24	$490M	$0	$490M
Q4 24	$468M	$0	$468M
Q1 25	$487M	$0	$487M
Q2 25	$539M	$0	$539M
Q3 25	$505M	$0	$505M
Q4 25	$545M	$0	$545M

Shares Outstanding

Revenue Per Employee

Revenue / Employee